Fibrocor Therapeutics.a privately-held Canadian developer of therapeutics to treat fibrosis.has named William Newsome III as president and chief executive and P 25 October 2023
German active pharmaceutical ingredient (API) manufacturer Axplora has appointed Stephan Haitz as president of the Novasep business unit. 19 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.